EDGAR Filing Documents for 0001171843-22-001460

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001171843-22-001460

Filing Date

2022-02-28

Accepted

2022-02-28 17:00:38

Documents

Period of Report

2021-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	bcrx20211231_10k.htm iXBRL	10-K	2035535
2	EXHIBIT 10.14	ex_340701.htm	EX-10.14	40108
3	EXHIBIT 10.72	ex_341111.htm	EX-10.72	904
4	EXHIBIT 10.76	ex_340702.htm	EX-10.76	1683
5	EXHIBIT 10.101	ex_340784.htm	EX-10.101	1150596
6	EXHIBIT 10.102	ex_340700.htm	EX-10.102	404641
7	EXHIBIT 10.103	ex_340699.htm	EX-10.103	358057
8	EXHIBIT 10.104	ex_340698.htm	EX-10.104	93504
9	EXHIBIT 21	ex_340697.htm	EX-21	7023
10	EXHIBIT 23	ex_338385.htm	EX-23	8010
11	EXHIBIT 31.1	ex_338405.htm	EX-31.1	11839
12	EXHIBIT 31.2	ex_338406.htm	EX-31.2	11814
13	EXHIBIT 32.1	ex_338407.htm	EX-32.1	5439
14	EXHIBIT 32.2	ex_338408.htm	EX-32.2	5344
20		exh1072.jpg	GRAPHIC	256347
21		exh1074_01.jpg	GRAPHIC	260691
22		exh1074_02.jpg	GRAPHIC	81729
23		perf.jpg	GRAPHIC	26924
	Complete submission text file	0001171843-22-001460.txt		12506576

Data Files

Seq	Description	Document	Type	Size
15	XBRL TAXONOMY EXTENSION SCHEMA	bcrx-20211231.xsd	EX-101.SCH	90184
16	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	bcrx-20211231_cal.xml	EX-101.CAL	60143
17	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	bcrx-20211231_def.xml	EX-101.DEF	582565
18	XBRL TAXONOMY EXTENSION LABEL LINKBASE	bcrx-20211231_lab.xml	EX-101.LAB	550622
19	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	bcrx-20211231_pre.xml	EX-101.PRE	616494
88	EXTRACTED XBRL INSTANCE DOCUMENT	bcrx20211231_10k_htm.xml	XML	1361021

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703

Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302

BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)